Swiss National Bank Vanda Pharmaceuticals Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$4.28 - $6.57 $17,548 - $26,937	4,100 Added 3.36%	126,300 $545,000
Q1 2023 May 10, 2023	SELL	$6.18 - $7.99 $88,992 - $115,056	-14,400 Reduced 10.54%	122,200 $829,000
Q4 2022 Feb 08, 2023	BUY	$6.87 - $10.96 $17,862 - $28,496	2,600 Added 1.94%	136,600 $1.01 Million
Q3 2022 Nov 09, 2022	BUY	$9.44 - $11.76 $21,712 - $27,048	2,300 Added 1.75%	134,000 $1.32 Million
Q1 2022 May 09, 2022	BUY	$10.84 - $16.55 $96,476 - $147,295	8,900 Added 7.25%	131,700 $1.49 Million
Q3 2021 Nov 08, 2021	BUY	$15.35 - $21.27 $27,630 - $38,286	1,800 Added 1.49%	122,800 $2.11 Million
Q2 2021 Aug 06, 2021	SELL	$15.71 - $21.51 $62,840 - $86,040	-4,000 Reduced 3.2%	121,000 $2.6 Million
Q1 2021 May 07, 2021	BUY	$13.42 - $20.28 $18,788 - $28,392	1,400 Added 1.13%	125,000 $1.88 Million
Q3 2020 Nov 09, 2020	BUY	$9.32 - $12.02 $35,416 - $45,676	3,800 Added 3.17%	123,600 $1.19 Million
Q2 2020 Aug 05, 2020	BUY	$9.66 - $12.02 $257,922 - $320,934	26,700 Added 28.68%	119,800 $1.37 Million
Q1 2020 May 08, 2020	BUY	$7.5 - $16.8 $9,750 - $21,840	1,300 Added 1.42%	93,100 $965,000
Q4 2019 Feb 06, 2020	BUY	$12.38 - $17.47 $28,474 - $40,181	2,300 Added 2.57%	91,800 $1.51 Million
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $17,178 - $22,106	1,400 Added 1.59%	89,500 $1.19 Million
Q2 2019 Aug 02, 2019	SELL	$13.37 - $18.85 $98,938 - $139,490	-7,400 Reduced 7.75%	88,100 $1.24 Million
Q1 2019 May 10, 2019	BUY	$17.59 - $31.05 $51,011 - $90,045	2,900 Added 3.13%	95,500 $1.76 Million
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $68,292 - $113,292	3,600 Added 4.04%	92,600 $2.42 Million
Q1 2018 May 04, 2018	BUY	$14.05 - $20.2 $273,975 - $393,900	19,500 Added 28.06%	89,000 $1.5 Million
Q3 2017 Nov 03, 2017	BUY	$15.4 - $18.85 $1.07 Million - $1.31 Million	69,500	69,500 $1.24 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

44.7M

Call Options Held

167K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$39.1 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.3 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.4 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.3 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$10.9 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account